Misa Tanaka

1.9k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Misa Tanaka is a scholar working on Finance, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Misa Tanaka has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Finance, 9 papers in Economics and Econometrics and 6 papers in Molecular Biology. Recurrent topics in Misa Tanaka's work include Banking stability, regulation, efficiency (11 papers), Global Financial Crisis and Policies (7 papers) and Economic theories and models (5 papers). Misa Tanaka is often cited by papers focused on Banking stability, regulation, efficiency (11 papers), Global Financial Crisis and Policies (7 papers) and Economic theories and models (5 papers). Misa Tanaka collaborates with scholars based in Japan, United Kingdom and United States. Misa Tanaka's co-authors include Pierre Monnin, Yannis Dafermos, Guido Schotten, Emanuele Campiglio, Josh Ryan‐Collins, Sandra Batten, Rhiannon Sowerbutts, Benjamin Nelson, David Aikman and Mariko Takeda‐Morishita and has published in prestigious journals such as Journal of Clinical Oncology, Kidney International and Nature Climate Change.

In The Last Decade

Misa Tanaka

31 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Climate change challenges for central banks and financial regulators

2018 459 citations Misa Tanaka et al. profile →

Peers

Countries citing papers authored by Misa Tanaka

Since Specialization

Citations

This map shows the geographic impact of Misa Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misa Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misa Tanaka more than expected).

Fields of papers citing papers by Misa Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misa Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misa Tanaka. The network helps show where Misa Tanaka may publish in the future.

Co-authorship network of co-authors of Misa Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Misa Tanaka. A scholar is included among the top collaborators of Misa Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misa Tanaka. Misa Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	J-TAIL-2: A prospective observational study of atezolizumab (atezo) combination therapy in patients (pts) with non-small cell lung cancer (NSCLC) in Japan. 2024 ·Journal of Clinical Oncology ·Yasutaka Watanabe, Makoto Nishio, Kadoaki Ohashi, Atsushi Osoegawa, Eiki Kikuchi, (unknown), (unknown), (unknown), Eisaku Miyauchi, Hiroshige Yoshioka, Ichiro Yoshino, Toshihiro Misumi, Masafumi Yamaguchi, (unknown), Masahiro Seike, Hironori Yoshida, Kazumi Nishino, (unknown), Misa Tanaka, Akihiko Gemma	0
2	J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan 2024 ·JTO Clinical and Research Reports ·Eisaku Miyauchi, (unknown), Kadoaki Ohashi, Atsushi Osoegawa, Eiki Kikuchi, (unknown), (unknown), (unknown), Hiroshige Yoshioka, Ichiro Yoshino, Toshihiro Misumi, (unknown), Masahide Oki, Takashi Kijima, Kenichi Chikamori, Kazumi Nishino, (unknown), (unknown), Misa Tanaka, Akihiko Gemma	0
3	Energy conversion efficiency comparison of different aqueous and semi-aqueous CO₂ electroreduction systems 2022 ·Analytical Methods ·Shofu Matsuda, Misa Tanaka, Minoru Umeda	8
4	Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study 2020 ·Asia-Pacific Journal of Clinical Oncology ·Takashi Nakano, Kozo Kuribayashi, Masashi Kondo, Masahiro Morise, Yuji Tada, Katsuya Hirano, (unknown), Misa Tanaka, Masataka Hirabayashi	4
5	Erlotinib plus bevacizumab (EB) versus erlotinib alone (E) as first-line treatment for advanced EGFR mutation–positive non-squamous non–small-cell lung cancer (NSCLC): Survival follow-up results of JO25567. 2018 ·Journal of Clinical Oncology ·Noboru Yamamoto, Takashi Seto, Makoto Nishio, Kōichi Goto, Isamu Okamoto, Takeharu Yamanaka, Misa Tanaka, Koji Takahashi, Masahiro Fukuoka, Nobuyuki Yamamoto	51
6	Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse 2017 ·Molecular Pharmaceutics ·Noriyasu Kamei, Misa Tanaka, Hayoung Choi, (unknown), (unknown), (unknown), Mariko Takeda‐Morishita	39
7	Let's Talk About the Weather: The Impact of Climate Change on Central Banks 2016 ·SSRN Electronic Journal ·Sandra Batten, Rhiannon Sowerbutts, Misa Tanaka	193
8	Dealing with a Banking Crisis: What Lessons Can Be Learned from Japan's Experience? 2014 ·SSRN Electronic Journal ·Benjamin Nelson, Misa Tanaka	5
9	Reputation, risk-taking, and macroprudential policy 2014 ·Journal of Banking & Finance ·David Aikman, Benjamin Nelson, Misa Tanaka	26
10	How Could Macroprudential Policy Affect Financial System Resilience and Credit? Lessons from the Literature 2013 ·SSRN Electronic Journal ·Julia Giese, Benjamin Nelson, Misa Tanaka, Nikola Tarashev	12
11	Multi-locus genotyping of bottom fermenting yeasts by single nucleotide polymorphisms indicative of brewing characteristics 2012 ·Journal of Bioscience and Bioengineering ·Shigehito Ikushima, (unknown), (unknown), (unknown), Misa Tanaka, (unknown), S. Mizutani, Osamu Kobayashi	0
12	All Together Now: Do International Factors Explain Relative Price Comovements? 2010 ·SSRN Electronic Journal ·Özer Karagedikli, Haroon Mumtaz, Misa Tanaka	4
13	The Economics of Global Output Gap Measures 2008 ·SSRN Electronic Journal ·Misa Tanaka, Chris Young	9
14	Acute Renal Failure After Exercise in a Japanese Sumo Wrestler With Renal Hypouricemia 2008 ·The American Journal of the Medical Sciences ·Akira Mima, Takeshi Matsubara, Hiroshi Kanamori, Emi Inui, Misa Tanaka, Y. Manabe, Noriyuki Iehara, (unknown), Motoko Yanagita, (unknown), Atsushi Fukatsu, Kimiyoshi Ichida, Tatsuo Hosoya, Hidenori Arai, Toru Kita, Masashi Kawamura, (unknown)	7
15	Roles of coagulation pathway and factor Xa in rat mesangioproliferative glomerulonephritis 2006 ·Laboratory Investigation ·Keiko Nomura, Ning Liu, Kojiro Nagai, (unknown), Ikei S. Kobayashi, Fumiaki Nogaki, Misa Tanaka, Hidenori Arai, Atsushi Fukatsu, Toru Kita, Takahiko Ono	25
16	Resolving Banking Crises - An Analysis of Policy Options 2006 ·SSRN Electronic Journal ·Misa Tanaka, Glenn Hoggarth	7
17	Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation 2005 ·Kidney International ·Misa Tanaka, Hidenori Arai, Ning Liu, Fumiaki Nogaki, Keiko Nomura, Kenji Kasuno, (unknown), Toru Kita, Takahiko Ono	41
18	The Na+-excreting efficacy of indapamide in combination with furosemide in massive edema 2005 ·Clinical and Experimental Nephrology ·Misa Tanaka, (unknown), Keiko Nomura, Fumiaki Nogaki, Atsushi Fukatsu, Kazuhide Uemura, Masatomo Yashiro, Takeshi Kimura, Eri Muso, (unknown)	10
19	Preparation, surface‐active properties, and antimicrobial activities of bis(alkylammonium) dichlorides having a butenylen or a butynylene spacer 2001 ·Journal of Surfactants and Detergents ·(unknown), Wanbin Zhang, Yohji Nakatsuji, (unknown), (unknown), Misa Tanaka, (unknown), Isao Ikeda	33
20	An Autopsy Case of Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like Episodes Syndrome with Chronic Renal Failure. 2001 ·Internal Medicine ·(unknown), Atsushi Oyama, Misa Tanaka, (unknown), (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact